Research Article

Evaluation for Retinal Therapy for RPE65 Variation Assessed in hiPSC Retinal Pigment Epithelial Cells

Figure 2

Characterisation of control and parental carrier (c.93A>G) hiPSC lines derived from human somatic cells. (a, b) Immunofluorescence detection of pluripotency markers NANOG, SSEA-4, OCT4, and SOX2 expressed in the nuclei of the control and carrier (c.93A>G) hiPSC lines. Nuclei stained with either Hoechst (cyan) or DAPI (blue), scale bar: 50 μm. (c, d) Verification of trilineage differentiation capacity of the control and carrier hiPSCs by RT-qPCR detection of increased relative gene expression of ectoderm (EN1, PAX6), endoderm (AFP, CDH20, and PHOX2B), and mesoderm (FOXF1, HAND2) markers in differentiated EBs compared to hiPSCs from both lines (unpaired -test, replicates, ; ). (e) SNP chromosome microarray analysis showing genome integrity and normal karyotype for the control and carrier hiPSCs.
(a)
(b)
(c)
(d)
(e)